.

ISSN 2063-5346
For urgent queries please contact : +918130348310

Pazopanib as a monotherapic anticancer drug

Main Article Content

Neha Bachhav1*, Dr Sarika Kamble2, Dr Laxmikant Borse2
» doi: 10.48047/ecb/2023.12.10.527

Abstract

Cancer is wide range of illnesses characterised by the expansion of abnormal cells with the ability to invade and damage healthy bodily tissue. Cancer is treated with a variety of chemotherapy or chemo medicines, Busulfan and the alkylating agent. Soft tissue sarcoma is uncommon kind which occurs in the tissues that encircle, link, and support other body structures. This includes the lining of your joints, blood vessels, muscle and blood vessels. The soft tissue sarcoma family includes 50 subtypes. Pazopanib is used to treat specific cancers (soft tissue sarcoma). Tyrosine kinase inhibitors are class of medications that includes pazopanib. Pazopanib treatment for soft tissue sarcoma and its mode of action are the current areas of emphasis.

Article Details